speb/financial-data huggingface dataset:
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — EBITDA: 13062000.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — End Cash Position: 22835000.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -1249000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 8031000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Fixed Assets Revaluation Reserve: 37621000.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 23708000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 1401000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 331567000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 116505000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Gross Profit: 25278000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Interest Expense: 415000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 395000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Interest Income: 67000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 67000.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -415000.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 0.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Inventory: 25497000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 186417000.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -229000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 44959000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 38997000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Net Debt: 3463000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Net Income: 7092000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 7092000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 7092000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Net Income Discontinuous Operations: 0.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Net Income Extraordinary: 0.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 7092000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 7092000.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 8653000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 7092000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Net Interest Income: -415000.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -834000.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -834000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -415000.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 82566000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Net PPE: 86243000.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -229000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 182028000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 3554000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 509000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 13042000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Normalized Income: 7092000.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 23937000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Operating Income: 4172000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Operating Revenue: 400353000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 16273800.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 264000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 1000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 19290000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Other Inventories: -1000.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 415000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -1000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 4897000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 8885000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Other Payable: 1465000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Other Properties: 2433000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 21909000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Payables: 277014000.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: 1921000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 5189000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Pretax Income: 8653000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 0.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -229000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 17467000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 375075000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 3994000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 0.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: -316944000.00
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 0.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 116000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 1517000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Share Issued: 16273800.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Special Income Charges: 0.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 182028000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 182028000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Tax Provision: 1561000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.25
BIOFILCHEM.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -1561000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Total Assets: 470827000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 182028000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Total Debt: 4389000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 182028000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Total Expenses: 396181000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 288799000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 86751000.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 3554000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 20000.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 0.00
BIOFILCHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Work In Process: 0.00
BIOFILCHEM.NS balance_sheet (annual, 2024-03-31) — Working Capital: 98831000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 227047000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 255113000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 16273800.00
BIOFILCHEM.NS income_statement (quarterly, 2024-09-30) — Basic EPS: 0.01
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 162738000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 1568000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 2202000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 162738000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 183965000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 336134000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 4551000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 4551000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 232882000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 671000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 16273800.00
BIOFILCHEM.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.01
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 68040000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 188516000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 2983000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 84268000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 183965000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 3554000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 16273800.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 10779000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 613000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 21227000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 1000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 634000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Payables: 227047000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-09-30) — Selling And Marketing Expense: 118000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 16273800.00
BIOFILCHEM.NS income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 183965000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 183965000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 420401000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 183965000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 4551000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 183965000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 236436000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 84269000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 3554000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
BIOFILCHEM.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 103252000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 3640000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 141952000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 16460000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 0.10
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 136227000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 987000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 987000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 16460000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.10
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 1646000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — EBIT: 2314000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — EBITDA: 3301000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 462000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 5725000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 98000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 98000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Net Income: 1646000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 1646000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 1645000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Net Income Extraordinary: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 1646000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 1646000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 1645000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -98000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -98000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 3301000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 1646000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Operating Income: 2085000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 141952000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 230000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 2216000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 136227000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 987000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 46000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Selling General And Administration: 508000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 571000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.26
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 139867000.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — +Operating Expense: 16236000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 5225000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — +Total Revenue: 334022000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 83510000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 309878000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 309878000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 383150000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 383150000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -34058000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 83331000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1704000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 16405882.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 16633333.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Basic EPS: 0.34
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.12
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 22835000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 30116000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -1001000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 162738000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 162738000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 2553000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1325000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2553000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2553000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 0.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 2553000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -7917000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -1078000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -1664000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Change In Payable: 34329000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -52859000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -29189000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -20282000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Common Stock: 162738000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 162738000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 187814000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 187816000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 0.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 0.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 313107000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 78039000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Current Assets: 425536000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 425536000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Current Debt: 4713000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 4713000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 4713000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 4713000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 2100000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 318477000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 318477000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 2100000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 2100000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Depreciation: 3796000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 3796000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 3796000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 834000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 3796000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 834000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 16405882.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 16633333.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Diluted EPS: 0.34
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.12
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 5578000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1997000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — EBIT: 7730000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — EBIT: 2613000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — EBITDA: 11526000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — EBITDA: 3447000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — End Cash Position: 2553000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -45000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 15921000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Fixed Assets Revaluation Reserve: 37621000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -20237000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 4155000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2088000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 384855000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 384855000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 117505000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Gross Profit: 20915000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 5471000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Interest Expense: 369000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 75000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 369000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 75000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -369000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 0.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Inventory: 33414000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 33414000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 192529000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 192529000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -1001000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 44959000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 39997000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Net Debt: 3388000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 3388000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Net Income: 5578000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income: 1997000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 5578000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1997000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 5578000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1997000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Net Income Discontinuous Operations: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 0.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Net Income Extraordinary: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Extraordinary: 0.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 5578000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1997000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 5578000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1996000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 7362000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 5578000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1997000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Net Interest Income: -369000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -75000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 324000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 324000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -369000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -75000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Net PPE: 83448000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 83447000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -1001000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 187814000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 187816000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 3312000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 3312000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 621000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 11526000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 3447000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Normalized Income: 5578000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 1997000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -19236000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Operating Income: 4679000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Operating Income: 246000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Operating Revenue: 334022000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 83510000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 16273800.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 16273800.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 6419000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 6419000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 1000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 25078000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 25078000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 369000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 620000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 620000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: -1000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 1000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 3052000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 2367000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 7337000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Other Payable: 1344000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 2433000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 1228000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1228000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Payables: 309878000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Payables: 311222000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 210000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 5999000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Pretax Income: 7361000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 2538000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -1001000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 313107000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 78039000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 3796000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 834000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: -311158000.00
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 0.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 435000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: -186000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 4590000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1902000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Share Issued: 16273800.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 16273800.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 187816000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 187814000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 187816000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 187816000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Tax Provision: 1783000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 541000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.24
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
BIOFILCHEM.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -1783000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Total Assets: 509604000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 509604000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 187816000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 187814000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Total Debt: 4713000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 4713000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 187816000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 187816000.00
BIOFILCHEM.NS income_statement (annual, 2025-03-31) — Total Expenses: 329343000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 83264000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 321788000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 321788000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 84068000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 84068000.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3313000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3313000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Work In Process: 0.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 0.00
BIOFILCHEM.NS balance_sheet (annual, 2025-03-31) — Working Capital: 107059000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 107059000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 5032000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 64326000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 16290541.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 1.48
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 59896000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 660000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 660000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 16290541.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.48
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 24110000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — EBIT: 27718000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — EBITDA: 28378000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 585000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 4430000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 93000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 93000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income: 24110000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 24110000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 24110000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Extraordinary: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 24110000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 24110000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 24110000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -93000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -93000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 28378000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 24110000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Operating Income: -602000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 64326000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 28320000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1683000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 27625000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 59896000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 660000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 585000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 3515000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.13
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 64928000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 3212000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 135408000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 333342000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 407700000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 16720000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.05
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 162738000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2344000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 3594000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 162738000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 213043000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 131712000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 484186000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 200000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 200000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 337282000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 3740000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 660000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 660000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 16720000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.05
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 836000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — EBIT: 1118000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — EBITDA: 1778000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 603000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 3696000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 1000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 34825000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 213243000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income: 836000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 836000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 836000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Extraordinary: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 836000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 836000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 836000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -1000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 69450000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 213043000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 3312000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1778000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 836000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Operating Income: 484000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 135408000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 16273800.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 38067000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 50305000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: -1000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 634000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 1250000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Payables: 333342000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 1117000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 131712000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 660000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 169000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 772000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 16273800.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 213043000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 213043000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 281000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 553636000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 213043000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 200000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 213043000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 134924000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 340593000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 69450000.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 3311000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
BIOFILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 146904000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 4024000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 8563000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 15840000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.05
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 4250000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 660000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 660000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 15840000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.05
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 792000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — EBIT: 1072000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — EBITDA: 1732000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1422000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 4313000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 5000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 5000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income: 792000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 792000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 792000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Extraordinary: 0.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 792000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 792000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 792000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -5000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -5000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1732000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 792000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Operating Income: 289000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 8563000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 783000.00
BIOFILCHEM.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00